Skip to content
OpenCapital
Get started

AbbVie ABBV Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

Cardinal Health logo
Cardinal HealthCAH
$160M-84.8%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$977M+3.6%
McKesson logo
McKessonMCK
$395M+3.9%
Cencora logo
CencoraCOR
$187.36M+12.2%
Bausch + Lomb logo
Bausch + LombBLCO
$73M+1.4%
Pfizer logo
PfizerPFE
——

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$444.6B+39.8%
P/E122.3×+37.8×
P/S7.1×+1.6×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%—
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's noncontrolling interests in subsidiaries?
AbbVie (ABBV) reported noncontrolling interests in subsidiaries of $44M in Q1 2026.
How has AbbVie's noncontrolling interests in subsidiaries changed year-over-year?
AbbVie's noncontrolling interests in subsidiaries increased by 4.8% year-over-year, from $42M to $44M.
What is the long-term trend for AbbVie's noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), AbbVie's noncontrolling interests in subsidiaries has grown at a 14.9% compound annual growth rate (CAGR), from $21M to $42M.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.